Hurl Drugs P Profile
Key Indicators
- Authorised Capital ₹ 0.40 M
- Paid Up Capital ₹ 0.10 M
- Company Age 34 Year, 3 Months
- Last Filing with ROC 31 Mar 2009
About Hurl Drugs P
Company Details
- Location
Patna, Bihar, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U00304BR1990PTC004242
- Company No.
004242
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Nov 1990
- Date of AGM
27 Sep 2009
- Date of Balance Sheet
31 Mar 2009
- Listing Status
Unlisted
- ROC Code
Roc-Patna
Who are the key members and board of directors at Hurl Drugs P?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ramesh Kumar ![]() | Managing Director | 21-Nov-1990 | Current |
Board Members (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Bharati Kesari ![]() | Director | 21-Nov-1990 | Current |
Financial Performance of Hurl Drugs P.
Enhance accessibility to Hurl Drugs P's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Hurl Drugs P?
Unlock access to Hurl Drugs P's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Charges (Loans)

There are no open charges registered against the company as per our records.
How Many Employees Work at Hurl Drugs P?
Unlock and access historical data on people associated with Hurl Drugs P, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Hurl Drugs P, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hurl Drugs P's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.